Related Experiment Video

Updated: Jul 14, 2026

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

Thymosin beta4 is cardioprotective after myocardial infarction

Deepak Srivastava1, Ankur Saxena, J Michael Dimaio

  • 1Gladstone Institute of Cardiovascular Disease, 1650 Owens Street, San Francisco, CA 94158, USA. dsrivastava@gladstone.ucsf.edu

Annals of the New York Academy of Sciences
|June 30, 2007
PubMed

Insights

Thymosin beta4 enhances cardiac cell migration and survival, promoting heart repair after injury. This peptide activates key survival pathways, offering a potential new therapy for myocardial damage.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Molecular Cardiology

Background:

  • Heart disease remains a significant cause of mortality.
  • Current cardiac repair strategies often rely on cell transplantation.
  • Novel therapeutic targets for myocardial repair are needed.

Purpose of the Study:

  • To investigate the role of thymosin beta4 in cardiac cell migration and survival.
  • To elucidate the molecular mechanisms underlying thymosin beta4's effects on cardiomyocytes.
  • To evaluate the therapeutic potential of thymosin beta4 in a mouse model of myocardial infarction.

Main Methods:

  • Assessed thymosin beta4's effects on cardiomyocyte and endothelial cell migration and survival in vitro.
  • Investigated the interaction of thymosin beta4 with PINCH and integrin-linked kinase (ILK).
  • Utilized a mouse model of myocardial infarction induced by coronary artery ligation.

Main Results:

  • Thymosin beta4 promoted myocardial and endothelial cell migration and enhanced cardiomyocyte survival.
  • Thymosin beta4 formed a complex with PINCH and ILK, activating Akt/PKB.
  • In vivo, thymosin beta4 treatment improved cardiac function and myocyte survival post-infarction.

Conclusions:

  • Thymosin beta4 facilitates cardiomyocyte and endothelial cell migration, survival, and cardiac repair.
  • The peptide's mechanism involves the PINCH-ILK-Akt pathway.
  • Thymosin beta4 represents a promising therapeutic candidate for acute myocardial damage.

More Related Videos

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice08:03

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Published on: March 30, 2022

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...